Liquid crystalline formulations containing modified surface TiO 2 nanoparticles obtained by sol-gel process

Journal of Sol-Gel Science and Technology

Volumn 63, Issue 2, 2012, Pages 251-257

  Manaia, Eloísa Berbel ^a   Kaminski, Renata Cristina Kiatkoski ^a   Soares, Christiane Pienna ^a   Meneau, Florian ^b   Pulcinelli, Sandra Helena ^a   Santilli, Celso V ^a   Chiavacci, Leila Aparecida ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^b SYNCHROTRON SOLEIL   (France)

Author keywords

Drug delivery; Liquid crystal; Sol gel process; TiO 2

Indexed keywords

ANTICANCER DRUG; CELL LINES; CELL VIABILITY; CHARGED SURFACES; CITOTOXICITY; CONTROLLED RELEASE SYSTEMS; COSMETIC FORMULATIONS; CRYSTALLINE STRUCTURE; HUMAN KERATINOCYTES; LIQUID CRYSTALLINE PHASE; LIQUID-CRYSTALLINE PHASIS; MODIFIED SURFACES; PH VALUE; SKIN CANCERS; SOL-GEL TRANSITIONS; SURFACE-MODIFIED; TIO; TITANIA NANOPARTICLES;

CELL CULTURE; CHARGED PARTICLES; DRUG DELIVERY; INORGANIC COMPOUNDS; LIQUID CRYSTALS; NANOPARTICLES; SOL-GEL PROCESS; SUN HOODS; TRANSPARENCY; ZETA POTENTIAL;

TITANIUM DIOXIDE;

EID: 84865312714     PISSN: 09280707     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10971-011-2673-7     Document Type: Conference Paper

References (29)

1. Wang SK, Balagula I, Osterwalder U (2010) Dermatol Ther 23:31-47.
2. Serpone N, Dondi D, Albini A (2007) Inorg Chim Acta 360:794-802.
3. Allena NS, Edgea M, Ortega A, Liauwa CM, Strattonb J, McIntyreb RB (2002) Polym Degrad Stab 78:468-478.
4. Jacobs JF, Poel EVD, Osseweijer P (2010) Nanoethics 4:103-113.
5. Senzui M, Tamura T, Miura K, Ikarashi Y, Watanabe Y, Fujii M (2010) J Toxical Sci 35:107-113.
6. Filipe P, Silva JN, Silva R, Castro JLCD, Gomes MM, Alves LC, Santus R, Pinheiro T (2009) Skin Pharmacol Physiol 22:266-275.
7. Zhang LW, Yu WW, Colvin VL, Monteiro-Riviere NA (2008) Toxicol Appl Pharmacol 228:200-211.
8. Jin CY, Zhu BS, Wang XF, Lu QH (2008) Chem Res Toxicol 21:1871-1877.
9. Sayes CM, Wahi R, Kurian PA, Liu Y, West JL, Ausman KD, Warheit DB, Colvin VL (2006) Toxicol Sci 92:174-185.
10. Alphonse P, Varghese A, Tendero C (2010) J Sol-Gel Sci Technol 56:250-263.
11. Zhou J, Zhao G, Ren X, Song B, Han G (2011) J Sol-Gel Sci Technol 58:148-155.
12. Scolan E, Sanchez C (1998) Chem Mater 10:3217-3223.
13. Kaminski RCK, Pulcinelli SH, Santilli CV, Meneau F, Blanchandin S, Briois V (2010) J Eur Ceram Soc 30:193-198.
14. Kaminski RCK, Pulcinelli SH, Judeinstein P, Meneau F, Briois V, Santilli CV (2010) J Phys Chem C 114:1416-1423.
15. Patravale VB, Mandawgade SD (2008) Int J Cosmet Sci 30:19-33.
16. Lopes L, Ferreira DA, Paula DD, Garcia MTJ, Thomazini JA, Fantini MCA, Bentley MVLB (2006) Pharm Res 23:1332-1342.
17. Hait SK, Moulik SP (2001) J Surfactants Deterg 4:303-309.
18. Croda (2002) Procetyl AWS Material Safety Data Sheet, Campinas. http://www.croda.com.br. Accessed 20 Jan 2011.
19. Ott LS, Finke RG (2007) Coord Chem Rev 251:1075-1100.
20. Stumm W, Morgan JJ (1996) Aquatic chemistry. Wiley-Interscience, New York.
21. Jiang J, Oberdöster G, Biswas P (2009) J Nanopart Res 11:77-89.
22. Gaisin NK, Gnezdilov OI, Pashirova TN, Zhiltzova EP, Lukashenko SS, Zakharova LY, Dzhabarov VI, Galyamedinov YG (2010) Colloid J 72:764-770.
23. Carvalho FC, Sarmento VHV, Chiavacci LA, Barbi MS, Gremiao MPD (2009) J Pharm Sci 99:2367-2374.
24. Dong YD, Boyd BJ (2011) Int J Pharm 417:101-111.
25. Wang Z, Zhou W (2009) J Solut Chem 38:659-668.
26. Klug HP (1954) X-ray diffraction procedures. Wiley, New York.
27. Negrini R, Mezzenga R (2011) Langmuir 27:5296-5303.
28. Lopes LB, Speretta FFF, Bentley MVLB (2007) Eur J Pharm Sci 32:209-215.
29. Vicentini FTMC, Casagrande R, Verri WA Jr, Georgetti SR, Bentley MVLB, Fonseca MJV (2008) AAPS J 9:591-596